Loading organizations...
Unexo Life Sciences develops and manufactures a range of innovative health solutions, specializing in topical and transdermal patches. The company leverages its expertise in patch technology to produce clinically certified, side-effect-free products for various ailments, including pain relief, cramp relief, fever cooling, and sleep promotion. It also functions as an OEM manufacturer, consistently aiming to develop solutions that demonstrate superior efficacy compared to existing topical options.
The company was founded in 2014 by Monika Bansal with the objective of creating and commercializing advanced healthcare products. Unexo Life Sciences began with an insight into the potential of transdermal delivery systems to offer convenient and effective alternatives for health management, particularly in the domain of pain and symptom relief.
Unexo Life Sciences serves a broad base of doctors and consumers globally, with its products readily available through medical stores and online platforms. The company’s vision is centered on manufacturing and marketing innovative health solutions that meet global quality standards, ensuring regulatory acceptance across diverse international markets.
Key people at UNEXO.
UNEXO was founded in 1993 by Jean Yves Carillet (President & Founder).
UNEXO has 3 tracked investments across 3 companies. The latest tracked deal is $12.7M Other Equity in Scalinx in February 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 3, 2021 | Scalinx | $12.7M Other Equity | Normandie Participations, Yves Guiol | BNP Paribas Développement, CEN Innovation |
| Jun 1, 2020 | Quortex | $3.0M Seed | Elaia Partners, GO Capital | Business Angels |
| Sep 3, 2019 | Robocath | $5.5M Other Equity | — | Caisse D'epargne, Crédit Agricole, GO Capital, M Capital, NCI, Normandie Participations, Supernova Invest |
Key people at UNEXO.
